{"id":"https://openalex.org/W2127104804","doi":null,"title":"A Phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancer.","display_name":"A Phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancer.","alternate_titles":[],"publication_year":1999,"publication_date":"1999-06-01","ids":{"openalex":"https://openalex.org/W2127104804","mag":"2127104804","pmid":"https://pubmed.ncbi.nlm.nih.gov/10389912"},"language":"en","primary_location":{"id":"pmid:10389912","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10389912","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial"},"parent_works":[],"lineage":["https://openalex.org/W2127104804"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054372225","display_name":"Linda Duska","orcid":"https://orcid.org/0000-0002-8878-4123","observed_orcids":["https://orcid.org/0000-0002-8878-4123"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L R Duska","raw_affiliation_strings":["Vincent Gynecology, Division of Gynecologic Oncology, Massachusetts General Hospital, Boston 02114, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vincent Gynecology, Division of Gynecologic Oncology, Massachusetts General Hospital, Boston 02114, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089955620","display_name":"Richard T. Penson","orcid":"https://orcid.org/0000-0002-8091-8588","observed_orcids":["https://orcid.org/0000-0002-8091-8588"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Penson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089509810","display_name":"Jeffrey G. Supko","orcid":"https://orcid.org/0000-0002-4599-3267","observed_orcids":["https://orcid.org/0000-0002-4599-3267"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J G Supko","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058502526","display_name":"Dianne M. Finkelstein","orcid":"https://orcid.org/0000-0001-9564-8181","observed_orcids":["https://orcid.org/0000-0001-9564-8181"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D M Finkelstein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037464387","display_name":"Thomas Makastorsis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Makastorsis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067587294","display_name":"James Gallagher","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Gallagher","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"K Borden","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Borden","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089632732","display_name":"Annekathryn Goodman","orcid":"https://orcid.org/0000-0002-7227-0902","observed_orcids":["https://orcid.org/0000-0002-7227-0902"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Goodman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112833608","display_name":"Arlan F. Fuller","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A F Fuller","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110173796","display_name":"Najamosama Nikrui","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Nikrui","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5000311133","display_name":"Michael V. Seiden","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M V Seiden","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.818,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.70794888,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":93},"biblio":{"volume":"5","issue":"6","first_page":"1299","last_page":"1305"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.8799999952316284},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9990000128746033},{"id":"https://openalex.org/keywords/continuous-infusion-chemotherapy","display_name":"continuous infusion chemotherapy","score":0.9190000295639038},{"id":"https://openalex.org/keywords/granulocyte-colony-stimulating-factor","display_name":"granulocyte colony-stimulating factor","score":0.9879999756813049},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8960000276565552},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9639999866485596},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7960000038146973},{"id":"https://openalex.org/keywords/steady-state-plasma-concentration","display_name":"steady-state plasma concentration","score":0.656000018119812},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.5960000157356262},{"id":"https://openalex.org/keywords/anemia","display_name":"anemia","score":0.593999981880188},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8830000162124634},{"id":"https://openalex.org/keywords/mucositis","display_name":"mucositis","score":0.8600000143051147}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7702172994613647},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.7353755831718445},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.7017194628715515},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.680889368057251},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6459259986877441},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5805243849754333},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5416250228881836},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.536468505859375},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5029157996177673},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5002894401550293},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.48026275634765625},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3749460279941559},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32895541191101074}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:10389912","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10389912","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial"},{"id":"mag:2127104804","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10389912","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W25774907","https://openalex.org/W1537889906","https://openalex.org/W1753106810","https://openalex.org/W1836451026","https://openalex.org/W1880426265","https://openalex.org/W1917258958","https://openalex.org/W1930308991","https://openalex.org/W1939163116","https://openalex.org/W1940922428","https://openalex.org/W1971445820","https://openalex.org/W1982222906","https://openalex.org/W1982230933","https://openalex.org/W1999672808","https://openalex.org/W2005779465","https://openalex.org/W2065393338","https://openalex.org/W2071479516","https://openalex.org/W2073894801","https://openalex.org/W2076024279","https://openalex.org/W2089887845","https://openalex.org/W2090101539","https://openalex.org/W2102903528","https://openalex.org/W2160207820","https://openalex.org/W2167805334","https://openalex.org/W2224245857","https://openalex.org/W2232368099","https://openalex.org/W2240623839","https://openalex.org/W2260083111","https://openalex.org/W2267902670","https://openalex.org/W2334195749","https://openalex.org/W2398538785","https://openalex.org/W2408244047","https://openalex.org/W2415089064","https://openalex.org/W2419567682"],"related_works":["https://openalex.org/W2014439227","https://openalex.org/W1967627421","https://openalex.org/W2155183904","https://openalex.org/W2095158688","https://openalex.org/W2049713407","https://openalex.org/W2401985421","https://openalex.org/W2021949334","https://openalex.org/W1835347798","https://openalex.org/W1753106810","https://openalex.org/W1974501335"],"abstract_inverted_index":{"A":[0,103],"Phase":[1],"I":[2],"study":[3],"of":[4,28,53,67,88,97,105,111,132,155,173,201],"paclitaxel":[5,39,202],"and":[6,26,119,137,160,186,203,218,225,233],"doxorubicin":[7,54,174,204,226],"administered":[8],"as":[9,178],"concurrent":[10],"96-h":[11],"continuous":[12,228],"i.v.":[13],"infusion":[14,229],"was":[15,41,55,73,116,141],"performed":[16],"to":[17,126],"determine":[18],"the":[19,94,101,149,166,171,206,211],"maximum":[20],"tolerated":[21,142],"dose":[22,40,52,163,168],"(MTD),":[23],"principal":[24],"toxicities,":[25],"pharmacokinetics":[27],"this":[29,176],"combination":[30],"in":[31,65,93,175,190,205],"women":[32],"with":[33,144],"relapsed":[34],"epithelial":[35],"ovarian":[36,239],"cancer.":[37,240],"The":[38,51,113,139],"fixed":[42],"at":[43,100,165,210],"100":[44],"mg/m2":[45,59,69],"(25":[46],"mg/m2/day":[47,61],"for":[48,62,237],"4":[49,63],"days).":[50],"escalated":[56],"from":[57],"30":[58],"(7.5":[60],"days)":[64],"increments":[66],"10":[68],"until":[70],"dose-limiting":[71],"toxicity":[72],"observed.":[74],"All":[75],"patients":[76,98,107,121,208],"received":[77,108,124],"granulocyte":[78],"colony-stimulating":[79],"factor":[80],"5":[81],"microg/kg/day":[82],"prophylactically.":[83],"Apparent":[84,194],"steady-state":[85,195],"plasma":[86,196],"levels":[87],"both":[89,135],"drugs":[90],"were":[91,182,213],"determined":[92],"final":[95],"cohort":[96],"treated":[99,209],"MTD.":[102],"total":[104],"17":[106],"52":[109],"cycles":[110],"therapy.":[112],"median":[114],"age":[115],"58":[117],"years,":[118],"all":[120],"had":[122],"previously":[123],"one":[125,187],"five":[127],"different":[128],"regimens":[129],"(median,":[130],"2)":[131],"chemotherapy,":[133],"including":[134],"platinum":[136],"paclitaxel.":[138],"treatment":[140],"well,":[143],"grade":[145],"1-2":[146],"nausea":[147],"being":[148],"most":[150],"frequent":[151],"side":[152],"effect":[153],"(73%":[154],"cycles).":[156],"Anemia,":[157],"neutropenia,":[158],"thrombocytopenia,":[159],"mucositis":[161],"became":[162],"limiting":[164],"fourth":[167],"level,":[169],"defining":[170],"MTD":[172,212],"regimen":[177,236],"50":[179],"mg/m2.":[180],"There":[181],"four":[183],"partial":[184],"responses":[185],"complete":[188],"response":[189],"15":[191],"evaluable":[192],"patients.":[193],"concentrations":[197],"(mean":[198],"+/-":[199,215,220],"SD)":[200],"three":[207],"33.9":[214],"12.5":[216],"nM":[217],"15.7":[219],"1.3":[221],"nM,":[222],"respectively.":[223],"Paclitaxel":[224],"by":[227],"is":[230],"a":[231],"well-tolerated":[232],"active":[234],"chemotherapy":[235],"recurrent":[238]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2127104804","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
